Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | PH-797804 | 0.6 | uM | 2 | IP-10 | 18.0 | 55 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | IP-10 | 15.5 | 66 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | IP-10 | 15.0 | 68 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | IP-10 | 15.0 | 50 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | IP-10 | 15.5 | 72 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | IP-10 | 14.0 | 52 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | IP-10 | 15.0 | 67 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | IP-10 | 14.0 | 62 | ||||
RA2159 | 2 | IP-10 | 17.0 | 72 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | IP-10 | 16.0 | 61 | ||||
N2645 | 2 | IP-10 | 15.5 | 64 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | IP-10 | 13.5 | 56 | ||||
RA2708 | 2 | IP-10 | 14.0 | 60 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | IP-10 | 33.0 | 43 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | IP-10 | 336.0 | 46 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | IP-10 | 29.5 | 42 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | IP-10 | 29.0 | 64 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | IP-10 | 35.0 | 63 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | IP-10 | 34.0 | 44 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | IP-10 | 3731.0 | 50 | |
RA2159 | TNF-a | 100 | ng/mL | 2 | IP-10 | 4169.0 | 49 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | IP-10 | 64.0 | 41 | |
N2645 | TNF-a | 100 | ng/mL | 2 | IP-10 | 583.5 | 56 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | IP-10 | 708.0 | 43 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | IP-10 | 870.5 | 34 |